Consider the recent price drop in TransMedics (TMDX) as a potential buying opportunity, as the market appears to be overreacting to a predictable seasonal slowdown. The company is performing strongly, having raised its full-year revenue guidance with analysts modeling 44% growth over the next year. Conversely, Enphase Energy (ENPH) faces significant headwinds from high interest rates and a clear competitive threat from Tesla (TSLA). With analysts predicting a 16% sales decline next year, the stock appears expensive even after its significant price fall. Therefore, investors should be cautious with ENPH as its core growth has stalled.

TransMedics (TMDX)

• The speaker owns this stock and considers it inexpensive at current levels.
• The stock dropped 8-9% after its Q3 earnings report. The speaker believes this is a market overreaction.
• The drop is attributed to the market forgetting that Q3 is a seasonally weak quarter for organ transplants. Q2 is typically stronger due to being the peak driving season, which unfortunately leads to more accidents and thus more organ availability.
• The company is growing very fast and raised its full-year revenue guidance to between $595 and $605 million.
• The speaker's model projects 44% revenue growth over the next 12 months, and even a more conservative 35% growth would still make the stock look cheap.
• The business is performing well, with liver transplants being the primary "cash cow."
• The company has a long-term goal of 10,000 transplants by 2028, which the speaker believes could make it a "multi-bagger" stock (meaning it could multiply its value several times over).

Takeaways

• Bullish Sentiment: The speaker is very positive about the company's long-term prospects.
• Potential Opportunity: The recent 8-9% price drop could be a buying opportunity for long-term investors, as it seems to be based on a predictable seasonal slowdown rather than a fundamental problem with the business.
• Key Growth Driver: The company's ability to continue growing its transplant volume, particularly in liver transplants, is the key factor to watch. The 2028 target of 10,000 transplants is a significant long-term benchmark.

SoFi Technologies (SOFI)

• The speaker owns this stock but now considers it expensive after a recent price spike.
• The stock is "firing on all cylinders," and the market is finally recognizing its strong performance.
• Falling interest rates are a major tailwind for SoFi. Lower rates encourage more people to take out personal and student loans, which is a core part of their business.
• SoFi's "one-stop shop" business model is working effectively. They are successfully cross-selling multiple products (investing, credit cards, bank accounts) to their members, with cross-buys increasing to 40%.
• Fee-based revenue now makes up 43% of their total revenue, providing a stable income stream.
• Key metrics are strong:
  • Member and product numbers are growing consistently.
  • Tangible book value, a key metric for banks, is growing very fast.
  • Credit quality is excellent. SoFi lends to borrowers with high FICO scores (around 750), resulting in low default rates (under 4%).

Takeaways

• Neutral to Bullish Sentiment: The speaker is bullish on the company's fundamentals but cautious about the stock's current high valuation.
• Hold, Don't Add: While the company is performing exceptionally well, the stock may have run up too much in the short term. The speaker is not adding to their position at these levels and would wait for a lower price to buy more.
• Interest Rate Sensitivity: SoFi's stock performance is closely tied to interest rate expectations. Continued signs of falling rates could provide a further boost to the stock, while rising rates would be a headwind.

Enphase Energy (ENPH)

• The speaker does not own this stock anymore, having sold it between $70 and $80.
• The company's business was "killed by interest rates." Higher rates made financing for residential solar systems much more expensive (from ~5% to ~13%), which destroyed consumer demand.
• A major new risk is competition from Tesla (TSLA), which the speaker sees as a "clear competitive threat."
  • Tesla's Powerwall 3 battery now includes its own inverter, making Enphase's microinverters redundant for customers who buy the Powerwall.
  • As Tesla dominates the EV market, customers are more likely to buy a Tesla-branded EV charger, hurting Enphase's expansion into that market.
  • Tesla is also launching its own complete solar panel solution.
• The company's growth has stalled. While revenue is slightly up from its bottom, it's nowhere near its boom years. Analysts are predicting a 16% decline in sales for the next year.
• Despite the stock price falling from over $150 to around $31, the speaker believes it is still expensive because the growth is gone. The valuation does not make sense for a company with flat or declining revenue.
• For the stock to recover, several things would need to happen: interest rates would need to fall significantly, the real estate market would need to rebound, and solar incentives would need to return.

Takeaways

• Bearish Sentiment: The speaker is negative on the stock's prospects due to fundamental challenges.
• Significant Headwinds: Strong competition from Tesla and the high-interest-rate environment pose major threats to Enphase's business model and growth potential.
• Valuation Trap: Investors should be cautious of viewing the stock as "cheap" just because it has fallen significantly from its peak. The underlying business is not growing, which may not justify its current price.